BioCorRx (BICX) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | 3.74% |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 57.05% |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | 26.65% |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 9.14% |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 18.17% |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 2.67% |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 12.72% |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | -33.78% |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | 38.05% |
| 10 | BioCorRx | - | - | 189,355.00 | 1.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.33% |
| Dec 31, 2025 | 26.64% |
| Sep 30, 2025 | 65.44% |
| Jun 30, 2025 | 0.12% |
| Mar 31, 2025 | -51.62% |
| Dec 31, 2024 | 0.85% |
| Sep 30, 2024 | -95.06% |
| Jun 30, 2024 | -77.17% |
| Mar 31, 2024 | -62.46% |
| Dec 31, 2023 | -52.06% |
| Sep 30, 2023 | -44.92% |
| Jun 30, 2023 | -48.73% |
| Mar 31, 2023 | -53.07% |
| Dec 31, 2022 | -70.40% |
| Sep 30, 2022 | -73.94% |
| Jun 30, 2022 | -71.50% |
| Mar 31, 2022 | -4.58% |
| Dec 31, 2021 | -32.55% |
| Sep 30, 2021 | 44.83% |
| Jun 30, 2021 | 6.81% |
| Mar 31, 2021 | 918.64% |
| Dec 31, 2020 | 273.73% |
| Sep 30, 2020 | 48.91% |
| Jun 30, 2020 | 20.10% |
| Mar 31, 2020 | 5.41% |
| Dec 31, 2019 | 164.83% |
| Sep 30, 2019 | 254.44% |
| Jun 30, 2019 | 60.01% |
| Mar 31, 2019 | 26.34% |
| Dec 31, 2018 | 8.33% |
| Sep 30, 2018 | 204.76% |
| Jun 30, 2018 | 65.26% |
| Mar 31, 2018 | -56.12% |
| Dec 31, 2017 | -40.23% |
| Sep 30, 2017 | 228.22% |
| Jun 30, 2017 | 38.09% |
| Mar 31, 2017 | 135.50% |
| Dec 31, 2016 | 9.48% |
| Dec 31, 2015 | 232.21% |
| Dec 31, 2014 | 217.67% |
| Dec 31, 2013 | 147.88% |